3.56MMarket Cap-351P/E (TTM)
1.345High1.130Low55.73KVolume1.320Open1.330Pre Close68.11KTurnover2.68%Turnover RatioLossP/E (Static)2.95MShares5.35252wk High4.45P/B2.51MFloat Cap1.13052wk Low--Dividend TTM2.08MShs Float1010.080Historical High--Div YieldTTM16.20%Amplitude1.130Historical Low1.222Avg Price1Lot Size
Shuttle Pharmaceuticals Stock Forum
Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
Huge difference though! Getting a patent application through doesn't mean anything revenue wise. You are only getting IP rights on the "idea" of the technology...
📊⚡️📊
No comment yet